Category:Dextroamphetamine
Jump to navigation
Jump to search
pharmaceutical drug | |||||
Upload media | |||||
Instance of |
| ||||
---|---|---|---|---|---|
Subclass of | |||||
Has use | |||||
Has part(s) | |||||
Physically interacts with |
| ||||
Mass |
| ||||
| |||||
![]() |
English: This category should contain images of dextroamphetamine, also known as (S)-(+)-amphetamine or D-amphetamine.
Media in category "Dextroamphetamine"
The following 33 files are in this category, out of 33 total.
-
(S)-Amphetamine Structural Formulae V1.svg 268 × 144; 7 KB
-
Amphetamine alpha.jpg 1,445 × 1,427; 116 KB
-
Amphetamine chiral synthesis ru.svg 720 × 130; 91 KB
-
Amphetamine resolution and chiral synthesis.svg 915 × 418; 64 KB
-
Amphetamine-3d-CPK.png 854 × 641; 127 KB
-
Amphetamine3D rendering.gif 512 × 512; 877 KB
-
D-Amphetamin.svg 207 × 88; 9 KB
-
D-Amphetamine molecule ball from xtal.png 3,000 × 1,931; 798 KB
-
D-Amphetamine molecule spacefill from xtal.png 3,000 × 2,157; 859 KB
-
D-Amphetamine-3D-balls.png 2,000 × 1,849; 470 KB
-
D-Amphetamine-3D-spacefill.png 2,000 × 1,884; 470 KB
-
D-amphetamine-3D-vdW.png 1,024 × 746; 156 KB
-
D-amphetamine.svg 127 × 54; 14 KB
-
Dekstroamfetamiinisulfaatti.JPG 1,100 × 825; 696 KB
-
Dexamfetamine2DACS.svg 85 × 48; 5 KB
-
Dexamfetamine3Dan.gif 256 × 256; 368 KB
-
Dexamphetamine sulfate 5 mg tablets.jpg 3,072 × 2,048; 5.25 MB
-
Dexamphetamine.png 91 × 121; 1 KB
-
Dexedrine 15mg.jpg 330 × 210; 32 KB
-
Dexedrine 5mg tablets.jpg 3,277 × 2,300; 2.16 MB
-
Dexedrine doj.jpg 166 × 257; 31 KB
-
Dexedrine doj2.jpeg 666 × 556; 220 KB
-
Dextroamphetamine synthesis 1.svg 512 × 51; 12 KB
-
Dextroamphetamine synthesis 2.svg 512 × 93; 8 KB
-
Dextroamphetamine synthesis 3.svg 512 × 105; 9 KB
-
Dextroamphetamine-2D-skeletal.png 1,100 × 527; 23 KB
-
Dextroamphetamine.jpg 1,741 × 2,027; 2.33 MB
-
Dextroamphetamine.png 528 × 289; 7 KB
-
DextroamphetamineSulfate costs (DrugStats).svg 1,024 × 768; 13 KB
-
DextroamphetamineSulfate prescriptions (DrugStats).svg 1,024 × 768; 9 KB
Categories:
- Amphetamine
- Anorectics
- Aphrodisiacs
- Cardiovascular drugs
- Nervous system drugs
- Enantiopure drugs
- Ergogenic aids
- Euphoriants
- Excitatory amino acid reuptake inhibitors
- Nootropics
- Norepinephrine-dopamine releasing agents
- Phenethylamines
- Stimulants
- TAAR1 agonists
- Attention deficit hyperactivity disorder management
- VMAT inhibitors
- World Anti-Doping Agency prohibited substances